Last reviewed · How we verify

NCT04272983

Population Study of the Prevalence of Celiac Disease and Other Gluten-dependent Disorders in Children and Adolescents

Completed Last updated 12 April 2021
What this trial tests

trial in Celiac Disease in Children in 3,070 participants. Completed in 31 December 2020.

Timeline
1 May 2016
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorI.M. Sechenov First Moscow State Medical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,070
Start date1 May 2016
Primary completion31 December 2020
Estimated completion31 December 2020
Sites1 location across Russia

Conditions studied

Sponsor

I.M. Sechenov First Moscow State Medical University

Who can join

Adults 7 to 18, any sex, with Celiac Disease in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the prevalence and clinical features of celiac disease in children to develop new treatment approaches and rehabilitation strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Celiac Disease in Children

Currently open trials in the same condition.

Other I.M. Sechenov First Moscow State Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04272983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing